Core Nursing Explanation
Key Concept Analysis: This question tests the critical nursing knowledge of medication management for a child in the acute phase of
Kawasaki disease (KD) with
coronary artery aneurysms. The core pathophysiology involves systemic vasculitis, which can lead to life-threatening complications like coronary artery dilation and aneurysms. The standard treatment in the acute phase is
high-dose intravenous immunoglobulin (IVIG) and
high-dose aspirin for its anti-inflammatory and anti-platelet effects. However, once the fever resolves, the aspirin dose is lowered for its anti-platelet (anti-clotting) effect to prevent thrombosis in the aneurysms. The key safety issue is the
Key Point! absolute contraindication of ibuprofen or other NSAIDs in a child on long-term, low-dose aspirin therapy, as they can antagonize aspirin's anti-platelet effect and increase the risk of coronary thrombosis.
Answer Rationale: The correct answer is to
Avoid giving aspirin and consult with the physician about fever management. This is correct because the parents are asking about fever management
specifically. The child is already on a therapeutic regimen (high-dose IVIG and aspirin). Giving
additional aspirin for fever would be incorrect dosing and could increase side effects. More importantly, the nurse should not independently administer other common antipyretics like
Watch out for confusion! ibuprofen or naproxen. The safest action is to hold any new medication and consult the physician to clarify the fever management plan within the context of the child's complex cardiac condition and current medications.
Distractor Analysis:
•
Option 1 (Administer acetaminophen): While acetaminophen is generally safe for fever in children, the nurse must first consider the child's overall treatment plan. The physician may have specific instructions regarding antipyretic use alongside high-dose aspirin. Administering it independently without consulting could overlook important clinical nuances. It is not the
most appropriate first action.
•
Option 2 (Apply cooling blankets): This is inappropriate. Cooling blankets or aggressive external cooling can cause shivering, which increases metabolic demand and can be distressing to a child. It is not a standard, comfort-focused nursing intervention for fever management in this context.
•
Option 3 (Encourage fluids and tepid sponge baths): While promoting fluid intake is always important for a febrile child, and tepid sponge baths can be a comfort measure, this option misses the critical pharmacological safety issue. It addresses supportive care but does not answer the parents' question about fever
management (which implies medication) or the need for professional consultation regarding drug interactions.
Related Concepts: The management of Kawasaki disease is phase-specific. The acute phase focuses on reducing inflammation with IVIG and high-dose aspirin. The subacute/convalescent phase focuses on preventing thrombosis in aneurysms with low-dose aspirin, sometimes with additional anticoagulants like clopidogrel or warfarin. Understanding this timeline is crucial for safe medication administration.
Concept Summary
•
Kawasaki Disease Acute Phase: High-dose IVIG + High-dose Aspirin (anti-inflammatory).
•
Kawasaki Disease Subacute/Convalescent Phase: Low-dose Aspirin (anti-platelet) for 6-8 weeks or longer if aneurysms present.
•
Critical Contraindication: Avoid ibuprofen/NSAIDs in children on long-term aspirin therapy due to increased thrombosis risk.
•
Fever in KD: Persistence or recurrence of fever after IVIG may indicate treatment resistance, requiring prompt physician notification.
Side-by-Side Comparison!
| Phase | Goal | Medication Regimen | Nursing Considerations |
|---|
| Acute (Fever Present) | Reduce inflammation, prevent coronary damage | IVIG single dose + High-dose Aspirin (80-100 mg/kg/day) | Monitor for IVIG reactions (fever, chills). High-dose aspirin carries risk of GI upset/hepatotoxicity. |
| Subacute/Convalescent (Afebrile) | Prevent thrombosis, especially in aneurysms | Low-dose Aspirin (3-5 mg/kg/day) | Educate parents to avoid NSAIDs (e.g., ibuprofen). Monitor for signs of bleeding or Reye's syndrome (vomiting, lethargy). |
Anatomy, Physiology & Pharmacology Points
•
Pathophysiology: KD causes inflammation of medium-sized arteries, particularly the
coronary arteries. This weakens the vessel wall, leading to aneurysm formation.
•
Pharmacology:
Aspirin has a dose-dependent effect. High dose: anti-inflammatory. Low dose: irreversibly inhibits platelet aggregation (anti-platelet).
Key Point! Ibuprofen can competitively block aspirin's binding site on platelets, negating its protective anti-clotting effect.
•
Reye's Syndrome: A rare but serious condition of acute encephalopathy and liver failure associated with aspirin use in children with viral infections. This is another reason for cautious aspirin use and parental education.
Memory Tips
•
KD Treatment Phases: "HIgh dose for High fever, Low dose for Long-term protection." (High-dose aspirin in acute phase, Low-dose in convalescent phase).
•
Drug Avoidance: "No NSAIDs for Aneurysm Kids." Remember that ibuprofen interferes with low-dose aspirin's anti-platelet effect.
High-Frequency NCLEX Topics
NCLEX frequently tests the
nurse's role in medication safety and patient education. For Kawasaki disease, expect questions on: 1) The purpose of IVIG and aspirin therapy, 2) Identifying signs of coronary artery involvement (e.g., chest pain, ECG changes), 3) Parent education points, especially regarding aspirin administration and avoiding NSAIDs.
Watch Out for Question Variations!
• Instead of fever management, the question could ask:
"The mother asks if she can give her child ibuprofen for leg pain. What is the nurse's best response?" (Answer: Educate about the interaction and advise against it).
• The scenario could shift to the
convalescent phase and ask about the purpose of low-dose aspirin (Answer: Anti-platelet therapy to prevent clots in aneurysms).
• It could be a priority question:
"A child with KD 2 weeks post-IVIG has a fever of 102°F. What is the priority action?" (Answer: Notify the physician, as this may indicate IVIG resistance or developing coronary complications).